Valentine K D, Leavitt Lauren, Atlas Steven J, Chen Emily, Ha Jasmine, Percac-Lima Sanja, Fairfield Kathleen M, Korsen Neil, Han Paul K J, Richter James M, Simmons Leigh, Sepucha Karen R
Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Darthmouth College, Hanover, NH, USA.
MDM Policy Pract. 2022 Dec 12;7(2):23814683221141377. doi: 10.1177/23814683221141377. eCollection 2022 Jul-Dec.
Early in the COVID-19 pandemic colonoscopies for colorectal cancer (CRC) screening were canceled. Patient perceptions of the benefits and risks of routine screening relative to health concerns associated with the COVID-19 pandemic were unknown. Assess patient anxiety, worry, and interest in CRC screening during the COVID-19 pandemic. A random sample of 200 patients aged 45 to 75 y with colonoscopy cancellation due to COVID-19 in March to May 2020 were surveyed. Anxiety, COVID-19 and CRC risk perceptions, COVID-19 and CRC worry, likelihood of following through with colonoscopy in the next month, and interest in alternatives to colonoscopy were assessed. Subsequent screening was tracked for 12 mo. Respondents ( = 127/200, 63.5%) were on average 60 y old, female (59%), college educated (62% college degree or more), and White (91%). A substantial portion of patients (46%) stated they may not follow through with a colonoscopy in the next month. There was greater interest in stool-based testing than in delaying screening (48% v. 26%). Women, older patients, and patients indicating tolerance of uncertainty due to complexity reported they were less likely to follow through with colonoscopy in the next month. Greater interest in stool-based testing was related to lower perceptions of CRC risk. Greater interest in delaying screening was related to less worry about CRC and less tolerance of risk. Over 12 mo, 60% of participants completed screening. Patients who stated they were more likely to screen in the next month were more likely to complete CRC screening ( = 0.01). Respondents who had a colonoscopy canceled during the COVID-19 pandemic varied in interest in rescheduling the procedure. A shared decision-making approach may help patients address varying concerns and select the best approach to screening for them.
In the wake of the first wave of the COVID-19 pandemic, almost half of patients stated they were not likely to follow through with a colonoscopy in the short term, about half were interested in screening with a stool-based test, and only one-quarter were interested in delaying screening until next year.Patients who perceived themselves at higher risk of colorectal cancer were less interested in stool-based testing, and patients who were more worried about colorectal cancer were less interested in delaying screening.A shared decision-making approach may be necessary to tailor screening discussions for patients during subsequent waves of the pandemic, other occasions where resources are limited and patient preferences vary, or where patients hold conflicting views of screening.
在新冠疫情初期,用于结直肠癌(CRC)筛查的结肠镜检查被取消。患者对于常规筛查的益处和风险相对于与新冠疫情相关的健康问题的认知尚不清楚。评估新冠疫情期间患者对CRC筛查的焦虑、担忧和兴趣。对2020年3月至5月因新冠疫情而取消结肠镜检查的200名45至75岁患者进行随机抽样调查。评估焦虑程度、对新冠和CRC风险的认知、对新冠和CRC的担忧、下个月进行结肠镜检查的可能性以及对结肠镜检查替代方法的兴趣。对后续筛查进行了12个月的跟踪。受访者(n = 127/200,63.5%)平均年龄为60岁,女性(59%),受过大学教育(62%拥有大学学位或更高学历),且为白人(91%)。很大一部分患者(46%)表示他们下个月可能不会去做结肠镜检查。与推迟筛查相比,患者对基于粪便的检测更感兴趣(48%对26%)。女性、老年患者以及表示因情况复杂而能容忍不确定性的患者表示,他们下个月进行结肠镜检查的可能性较小。对基于粪便检测的更大兴趣与对CRC风险的较低认知有关。对推迟筛查的更大兴趣与对CRC的较少担忧和较低的风险容忍度有关。在12个月内,60%的参与者完成了筛查。表示下个月更有可能进行筛查的患者更有可能完成CRC筛查(P = 0.01)。在新冠疫情期间结肠镜检查被取消的受访者对重新安排检查的兴趣各不相同。共同决策的方法可能有助于患者解决不同的担忧,并为他们选择最佳的筛查方法。
在新冠疫情的第一波冲击之后,几乎一半的患者表示他们短期内不太可能去做结肠镜检查,约一半的患者对基于粪便的检测筛查感兴趣,只有四分之一的患者对推迟筛查到明年感兴趣。认为自己患结直肠癌风险较高的患者对基于粪便的检测兴趣较低,而对结直肠癌更担心的患者对推迟筛查兴趣较低。在疫情的后续阶段、资源有限且患者偏好各异的其他情况下,或者患者对筛查持有相互冲突观点的情况下,可能需要采用共同决策的方法来为患者量身定制筛查讨论。